Millennium Management
RIGL icon

Millennium Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Millennium Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100,000
Closed -$3.54M – 4115
2018
Q1 		$3.54M Buy
+100,000
New +$4M ﹤0.01% 2008
2016
Q4 		– Sell
-15,000
Closed -$551K – 3659
2016
Q3 		$551K Buy
+15,000
New +$430K ﹤0.01% 2555

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's RIGL Position: Q1 2026 in Review

Millennium Management reduced its Rigel Pharmaceuticals (RIGL) stake by 39% in Q1 2026, selling an estimated $5.61M and leaving 264,410 shares worth $7.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

Millennium Management first reported a position in RIGL in Q2 2013 and has held it in 50 quarters since. The position peaked at $24.5M in Q3 2018. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Millennium Management held 264,410 shares of Rigel Pharmaceuticals worth $7.15M as of Q1 2026.
  • Millennium Management sold 167,050 Rigel Pharmaceuticals shares in Q1 2026, an estimated $5.61M.
  • Rigel Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2544 holding.
  • Millennium Management first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • Millennium Management's Rigel Pharmaceuticals position peaked at $24.5M in Q3 2018.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.